Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Online decision aid for choosing stroke prevention treatment in atrial fibrillation

Tests a digital decision tool for people with newly diagnosed atrial fibrillation.

Plain-language title generated from the registry record
Registry title: RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

Key facts

Where
Calgary, CanadaSee the 2 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a recent diagnosis of atrial fibrillation not caused by a heart valve problem, who have a first specialist visit coming up and are thinking about stroke prevention treatment.

Age
18 years or older
Sex
All sexes can join
Disease stage
Atrial fibrillation not caused by a heart valve problem, diagnosed within the last 12 months, with any level of stroke risk. First specialist visit for atrial fibrillation booked in 7-30 days.
Earlier treatment
No blood-thinning pills (oral anticoagulants), or taking them for less than 90 days.

Main reasons for not taking part

  • Atrial fibrillation caused by a mechanical heart valve or mitral valve narrowing (mitral stenosis)
  • Taking two antiplatelet drugs together for a reason other than atrial fibrillation
  • Another medical reason, apart from atrial fibrillation, to take blood-thinning pills
  • Cannot use web-based tools, for example no internet access or limited English reading skills (Grade 5 level)

Read by machine on 9 November 2026.

Where in Canada

  • Calgary Zone, Alberta Health ServicesCalgary, CanadaTaking people
  • Vita DiagnosticsCalgary, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Calgary
Trial code
NCT05900414
Record updated
2 April 2025
Original description
The goal of this pilot clinical trial is to evaluate the utility of a new electronic patient decision aid for stroke prevention therapy in patients with atrial fibrillation. The main questions it aims to answer are:Read full original descriptionShow less

Pilot Clinical Trial of the Risk Assessment and Personal Preference to Improve Decisions in Atrial Fibrillation Patient Decision Aid for Stroke Prevention in Atrial Fibrillation: the RAPID AFib Pilot Trial.

The goal of this pilot clinical trial is to evaluate the utility of a new electronic patient decision aid for stroke prevention therapy in patients with atrial fibrillation. The main questions it aims to answer are:

Is the patient decision aid acceptable to both patients and physicians? Does the patient decision aid lead to more effective shared decision-making than standard care among patients with atrial fibrillation who are considering stroke prevention therapy? Participants with a recent diagnosis of atrial fibrillation will be enrolled before an upcoming specialist physician visit. Researchers will compare a pre-visit intervention consisting of standard educational materials plus use of the patient decision aid to educational materials alone to see if using the decision aid results in improved shared decision making during the clinic visit.

Inclusion: Non-valvular AF diagnosed within 12 months, with any level of stroke risk assessed by CHA2DS2-VASc score; Age 18 or older; Either no OAC treatment or treated for less than 90 days; Initial specialist AF visit scheduled in 7-30 days.

Exclusion: Currently prescribed dual antiplatelet therapy (ASA plus either clopidogrel, ticagrelor, or prasugrel) for an indication other than AF; Valvular AF, defined, per Canadian Cardiovascular Society Guidelines, as AF in the presence of mechanical heart valves, rheumatic mitral stenosis, or moderate to severe nonrheumatic mitral stenosis; Has an independent, non-AF indication for oral anticoagulation; Has a non-modifiable impediment to effective use of web-based tools. Examples include lack of internet access, lack of English literacy (Grade 5 level).

ClinicalTrials.gov NCT05900414